ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
47 announcements with these filters
Vijaya Diagnostic delivered strong Q2 growth, leveraging operating leverage and CGHS tariff revisions to expand margins significantly despite aggressive network expansion.
Q2 FY27 revenue ₹2,554 Mn (+26.7%), EBITDA ₹1,128 Mn (44.1% margin), PAT ₹595 Mn (23.3%). Strategy: hub-and-spoke densification, Bengaluru/Hyderabad hubs, Guwahati entry.
Vijaya Diagnostic's Q2 FY27 press release reports revenue up 26.7% and PAT up 37.4% year-on-year. It also notes an agreement to acquire Arya Wellness Centre in Guwahati.
Vijaya Diagnostic Centre appointed Rahul Jain as Company Secretary and Compliance Officer, designated KMP, effective November 03, 2026. The appointment follows the Nomination and Remuneration Committee's recommendation.
Vijaya Diagnostic Centre Ltd reported revenue from operations of ₹255.4 Cr (+26.7% YoY) and net profit of ₹59.5 Cr (+37.4% YoY) for Q2 FY27.
Vijaya Diagnostic Centre scheduled a board meeting for 3 Nov 2026 to approve unaudited Q1 and H1 FY27 results. No financial figures or material decisions are disclosed in this notice.
Vijaya Diagnostic Centre Ltd has filed its quarterly shareholding pattern as mandated by SEBI regulations. This report details the share distribution among various shareholder categories.
Vijaya Diagnostic Centre held its 24th Annual General Meeting on September 24, 2026. Shareholders transacted ordinary and special business, including declaring a final dividend.
Vijaya Diagnostic Centre is acquiring 100% of Arya Wellness Centre in Guwahati. The company published an investor presentation detailing the acquisition's strategic rationale and financial highlights.
Vijaya Diagnostic Centre acquires the diagnostic business undertaking of Arya Wellness Centre for ₹46.20 Crore on a slump sale basis to expand its North-East India presence.
Vijaya Diagnostic Centre Ltd acquired the integrated diagnostic business of Arya Wellness Centre for ₹46.20 Crore. This slump sale expands its presence into the North-East.
Vijaya Diagnostic Centre Limited has appointed Dr. Venkata Naresh Yallapragada as the new Chief Information Officer (CIO). This leadership change is effective from September 2, 2026.
Vijaya Diagnostic Centre Ltd has sent web-link letters to shareholders whose email addresses are not registered, enabling access to the Annual Report for FY 2025-26.
Vijaya Diagnostic Centre Limited filed its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26, fulfilling mandatory SEBI regulatory reporting requirements.
Vijaya Diagnostic Centre Ltd submitted its Annual Report for FY 2025-26, which includes the notice for the 24th Annual General Meeting scheduled for September 24, 2026.
Dr. Manjula Anagani has ceased to be an Independent Director of Vijaya Diagnostic Centre Ltd effective August 21, 2026, upon the completion of her tenure.
Vijaya Diagnostic Centre will hold its 24th Annual General Meeting on September 24, 2026. The company fixed September 16, 2026, as the record date for dividend entitlement.
Vijaya Diagnostic Centre distributed Rs. 0.52 Crore in net sale proceeds from fractional entitlements to shareholders. This follows its NCLT-approved amalgamation with Medinova Diagnostic Services.
Vijaya Diagnostic reports strong Q1 FY27 results with 22.8% YoY revenue growth, driven by volume expansion and new hub commissions in Bengaluru and Hyderabad.
Vijaya Diagnostic Centre reported Q1 FY27 results with 22.8% YoY revenue growth. The company also commissioned four new spokes in Hyderabad, Andhra Pradesh, and Pune.
Vijaya Diagnostic Centre Ltd reported revenue from operations of ₹231 Cr (+22.8% YoY) and net profit of ₹53.1 Cr (+37.6% YoY) for Q1 FY27.
HDFC Mutual Fund acquired shares of Vijaya Diagnostic Centre, taking its total holding to 5.003% of the paid-up equity share capital.
Vijaya Diagnostic Centre scheduled a board meeting for August 6, 2026. The board will consider un-audited financial results for the quarter ended June 30, 2026.
The company filed its quarterly shareholding pattern under SEBI Regulation 31(1)(b) for the period ending June 30, 2026, disclosing promoter and public shareholdings.
Vijaya Diagnostic Centre allotted 100,987 equity shares under the VDCL Employee Stock Option Plan 2018. This allotment expands the company's issued share capital.
Vijaya Diagnostic Centre Ltd issued a Postal Ballot notice seeking shareholder approval for the appointment of two Independent Directors. E-voting runs from July 21 to August 20, 2026.
Vijaya Diagnostic Centre granted 90,000 ESOPs at Rs. 956 per share, totaling Rs. 8.60 Crore. Options vest over three years for support function employees.
Vijaya Diagnostic Centre appointed Mr. Narasimha Raju K.A. as Chief Financial Officer effective July 09, 2026. He brings over 20 years of experience, previously serving at Yashoda Hospitals.
abrdn Asia Limited sold 133,199 shares (≈0.13% of capital) of Vijaya Diagnostic Centre Ltd in an open‑market transaction. Its stake fell from 3.37% to 3.24%.
Mr. Ankit Shah has resigned as Chief Financial Officer of Vijaya Diagnostic Centre effective July 24, 2026. The company is now identifying a suitable successor.